Secukinumab receives FDA approval for psoriatic arthritis, ankylosing spondylitis
18/01/2016 - 20:02
The Food and Drug Administration approved two new indications for the interleukin-17A inhibitor secukinumab (Cosentyx) – psoriatic arthritis in adul... More »
